GlaxoSmithKline Pharmaceuticals is currently trading at Rs. 2479.90, up by 16.95 points or 0.69% from its previous closing of Rs. 2462.95 on the BSE.
The scrip opened at Rs. 2470.70 and has touched a high and low of Rs. 2480.00 and Rs. 2460.00 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2899.00 on 03-Jun-2013 and a 52 week low of Rs. 2005.00 on 01-Feb-2013.
Last one week high and low of the scrip stood at Rs. 2573.00 and Rs. 2454.00 respectively. The current market cap of the company is Rs. 21,005.00 crore.
The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.37% and 14.96% respectively.
GlaxoSmithKline Pharmaceuticals’ (GSK Pharma) sales resumed as traders have started purchasing company’s products across the country since last week of November 2013. The sales were affected earlier in the major pockets of the country as the company’s products were not being purchased by stockists and retailers from September 15, 2013.
GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1783.25 |
Dr. Reddys Lab | 1211.00 |
Cipla | 1486.80 |
Lupin | 2056.70 |
Zydus Lifesciences | 946.50 |
View more.. |